What is Asthma?
Asthma is characterized by airway inflammation, reversible airway obstruction, and airway sensitivity. Common symptoms include recurrent wheezing, shortness of breath, cough, and chest tightness. Asthma continues to be a major health concern worldwide, with a global prevalence of approximately 300 million and continuing to grow.
Asthma shouldn’t interfere with your quality of life. When asthma is managed with medication and a healthy lifestyle, people with asthma can stay in control of their symptoms and lead a normal life.
About the Study:
This study is testing the safety and efficacy of an investigational treatment for asthma in comparison to already FDA approved QVAR® inhaler and placebo. The study medication being evaluated is a potential generic version of an already approved medication. If enrolled in the study, participants can expect to spend up to 6 weeks in the study, including an initial screening and baseline visit followed by scheduled clinic visits.
Fequently Asked Questions:
What is a clinical research study?
A clinical research study tests the safety and efficacy of an investigational medicine or treatment in a population of volunteers. Every medical breakthrough goes through the clinical trial process, so participants like you play a very important role in advancing medicine for present and future generations.
Why should I participate?
• Take an active role in your treatment
• Contribute to medical research and help to shape the future of asthma treatments
• All study related medications, office visits and examinations are free
How are my rights and safety protected as a patient during a clinical trial?
Protecting the health and safety of people who take part in clinical trials is the highest priority for clinical researchers throughout the entire study process. All clinical trials follow strict federal guidelines on how volunteers must be treated.
For more information on these types of studies, please call Advanced Research for Health Improvement in Collier County.
239-230-2021
Hablamos español
To pre-qualify for this study, you must:
• Be between 18 and 70 years of age
• Diagnosed with asthma for at least one year
• Must be on a stable dose asthma treatment
for the past four weeks
Qualified participants, will receive:
• Study related medications
• Office visits and examinations at no cost
• Compensation for time and travel may be provided
Health insurance is not needed to participate.